Investment Summary

Arsenal Capital Partners Invests In AvCarb

On November 2, 2021, private equity firm Arsenal Capital Partners invested in manufacturer AvCarb

Investment Highlights
  • This is Arsenal Capital Partners’ 2nd transaction in the Manufacturing sector.
  • This is Arsenal Capital Partners’ 44th transaction in the United States.
  • This is Arsenal Capital Partners’ 1st transaction in Massachusetts.

Investment Summary
Date 2021-11-02
Target AvCarb
Sector Manufacturing
Investor(s) Arsenal Capital Partners
Deal Type Growth Capital
Advisor(s) Houlihan Lokey (Financial)

Target

AvCarb

Lowell, Massachusetts, United States
AvCarb is a manufacturer of application-enabled carbon components for hydrogen fuel cells and electrolyzers, flow batteries, automotive and industrial applications. AvCarb's main products include engineered carbon-based products, such as advanced gas diffusion layers and molded graphite layers, woven carbon fabrics, and carbon felts used in electrochemical and friction applications. AvCarb is based in Lowell, Massachusetts.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Arsenal Capital Partners

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2000
PE ASSETS 10.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Arsenal Capital Partners is a private equity firm focused on middle-market healthcare, specialty industrial, and financial service companies. Specifically, Arsenal looks to acquire businesses in the areas of specialty chemicals, aerospace/defense, transportation, environmental services, business services, insurance, asset management, financial technology, medical products, healthcare IT, and healthcare contract research/manufacturing. The Firm typically seeks to commit $50 to $300 million per investment in profitable businesses with at least $10 million of EBITDA. Funds are generally used to support buyouts, recapitalizations, growth financings, consolidations, and divestitures. The Firm avoids investing in companies reliant on high levels of technology. Arsenal Capital Partners was formed in 2000 and is headquartered in New York City.

DEAL STATS #
Overall 49 of 57
Sector (Manufacturing) 2 of 3
Type (Growth Capital) 4 of 5
State (Massachusetts) 1 of 2
Country (United States) 44 of 50
Year (2021) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-24 BioIVT

Hicksville, New York, United States

BioIVT is a provider of biological products to life sciences and pharmaceutical companies. BioIVT specializes in control and disease state matrices manufactured from human and animal blood, plasma, serum, tissues, and other fluids which are used in drug discovery, compound development, clinical and research diagnostics. BioIVT was founded in 1981 and is based in Hicksville, New York.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-18 Invio Automation

Lansing, Michigan, United States

Invio Automation designs, builds, and sustains advanced industrial solutions used to solve complex manufacturing needs. The company's proven portfolio of Industry 4.0 technology includes autonomous guided vehicles (AGVs), collaborative robot systems, traditional robotics, assembly automation & simulation, 3D printing tool development & production, and Factory of the Future consulting for manufacturers. Invio Automation was formed in 1974 and is based in Lansing, Michigan.

Buy -
Mergr

Product

Company

Legal